Transdermal formulations, methods and devices
US5198223A · kind A · utility
24Cited by
21References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 1992 |
| Grant date | Mar 30, 1993 |
| Priority date | — |
| Expiry date | Mar 9, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for the transdermal administration of a therapeutically effective amount of a synthetic 19-nor-progesterone (ST-1435) and an estrogen, in combination, together with, optionally, a suitable permeation enhancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.